Literature DB >> 190750

Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors.

H W Seyberth, G V Segre, P Hamet, B J Sweetman, J T Potts, J A Oates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 190750

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  7 in total

Review 1.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

2.  Disequilibrium hypercalcaemia.

Authors:  D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

3.  Management of severe hypercalcaemia.

Authors: 
Journal:  Br Med J       Date:  1980-01-26

Review 4.  Hypercalcemia and cancer: an update.

Authors:  T M Murray; R G Josse; J N Heersche
Journal:  Can Med Assoc J       Date:  1978-10-21       Impact factor: 8.262

Review 5.  [Hypocalcemia in malignant diseases].

Authors:  E Heidbreder; K Schafferhans; A Heidland
Journal:  Klin Wochenschr       Date:  1983-08-15

6.  Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.

Authors:  R G Josse; T M Murray; G R Mundy; D Jez; J N Heersche
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

7.  Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma.

Authors:  H W Seyberth; G Bonsch; H Müller; H W Minne; T Erlenmaier; K Strein; H Imbeck; R Mrongovius
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.